Related Experiment Videos
Whipple's disease.
1Department of Rheumatology, Centre Hospitalier du Mans, Le Mans, France. xpuechal@ch-lemans.fr
Joint Bone Spine
|May 25, 2002
Summary
Whipple's disease, a bacterial infection by Tropheryma whippelii, presents with joint pain preceding digestive issues. New PCR tests aid diagnosis, but T. whippelii is not a common cause of unexplained arthritis.
Area of Science:
- Infectious Diseases
- Rheumatology
- Gastroenterology
Background:
- Whipple's disease is a chronic systemic bacterial infection caused by Tropheryma whippelii, primarily affecting middle-aged men.
- Joint manifestations often precede gastrointestinal symptoms by several years, making early diagnosis challenging.
- Traditional diagnosis relies on identifying PAS-positive macrophages in biopsies, but atypical presentations exist.
Purpose of the Study:
- To review the current understanding of Whipple's disease, focusing on diagnostic advancements and clinical spectrum.
- To evaluate the utility of PCR testing for Tropheryma whippelii in diagnosing joint manifestations.
- To highlight the potential for earlier diagnosis and improved patient outcomes.
Main Methods:
- Review of recent literature on Whipple's disease diagnosis and clinical presentation.
- Discussion of PCR-based diagnostic tests for detecting Tropheryma whippelii nucleic acids in various body fluids.
- Analysis of studies investigating the role of T. whippelii in unexplained arthritis.
Main Results:
- PCR testing is valuable for early or atypical Whipple's disease, detecting T. whippelii in joint fluid.
- Studies indicate T. whippelii is not a common cause of unexplained seronegative oligoarthritis or polyarthritis.
- Recent isolation of the organism may lead to serological tests, potentially improving diagnosis.
Conclusions:
- Advances in detecting and isolating Tropheryma whippelii suggest Whipple's disease may be more common and diverse than previously thought.
- PCR testing is a useful tool, particularly in joint specimens, but further research is needed to define optimal patient subsets.
- Earlier diagnosis through improved methods holds promise for preventing severe systemic complications.